FreeMesotheliomaInfo.com

This volume presents a rigorous account of statistical forecasting efforts that led to the successful resolution of the Johns-Manville asbestos litigation. This case, taking 12 years to reach settlement, is expected to generate nearly 500,000 claims at a total nominal value of over $34 billion. The forecasting task, to project the number, timing, and nature of claims for asbestos-related injuries from a set of exposed persons of unknown size, is a general problem: the models in this volume can be adapted to forecast industry-wide asbestos liability. More generally, because the models are not overly dependent on the U.S. legal system and the role of asbestos as a dangerous/defective product, this volume will be of interest in other product liability cases, as well as similar forecasting situations for a range of insurable or compensable events.

The volume stresses the iterative nature of model building and the uncertainty generated by lack of complete knowledge of the injury process. This uncertainty is balanced against the Court’s need for a definitive settlement, and the volume addresses how these opposing principles can be reconciled. The volume is written for a broad audience of actuaries, biostatisticians, demographers, economists, epidemiologists, environmental health scientists, financial analysts, industrial-risk analysts, occumpational health analysts, product liability analysts, and statisticians. The modest prerequisites include basic concepts of statistics, calculus, and matrix algebra. Care is taken that readers without specialized knowledge in these areas can understand the rationale for specific applications of advanced methods. As a consequence, this volume will be an indispensable reference for all whose work involves these topics.

The authors analyze the costs and compensation paid for asbestos personal-injury claims, and discuss such issues as the current state of asbestos litigation in the United States, the costs of compensation, the effects of litigation on businesses, and the evolving character of litigation.

This book provides a wealth of useful information on various types of lung cancers, medical trials, treatments and medications. – Books on Living with Mesothelioma and Cancer – Early, Ludwick, Sweeney & Strauss Books on Living with Mesothelioma and Cancer – Early, Ludwick, Sweeney & Strauss –This text refers to the Paperback edition.

Lung cancer and Mesothelioma is a comprehensive reference for lung cancer. Comprising 41 chapters and 480 pages, the book reviews chemotherapy, radiation, surgery, and gene therapy and many other topics. Learn how the new gene therapies work, what chemotherapy is designed to do, how lung tumors are categorized and why they metastasize. Each form of therapy and each stage of disease has its own chapter for easy reference. Thus you can review material on radiation treatments, or stage 1 non-small cell lung cancer in a single chapter.

The book is designed to help you understand a difficult subject and interact with your doctor to make meaningful choices. It examines traditional therapies as well as new drugs like Tarceva and investigational therapies, and provides numerous references and directions for further research.

Utilizing his experience as a caregiver, the author discusses the stresses and practical realities of dealing with lung cancer. There are chapters on chemotherapy side effects, insurance questions, and the pressures of caregiving. Where are support groups located, what help can you provide when someone is hospitalized, and how do you talk about a serious illness are among the questions the book tries to answer. –This text refers to the Paperback edition.